Suchergebnisse - "Keshavarz, Khosro"

PubPharm (91)

1

Cost-effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients with Metastatic Prostate Cancer : A Societal Perspective

enthalten in: Value in health regional issues | 2024

von Rezaee, M. | Karimzadeh, I. | Hashemi-Meshkini, A. | +4

2

Cost-effectiveness and budget impact analysis of enzalutamide in comparison to abiraterone in treatment of metastatic prostate cancer resistant to castration in Iran

enthalten in: BMC urology | 2024

von Goudarzi, Z. | Lotfi, F. | Najafpour, Z. | +3

3

Cost-effectiveness and budget impact analysis of enzalutamide in comparison to abiraterone in treatment of metastatic prostate cancer resistant to castration in Iran

enthalten in: BMC urology | 2024

von Goudarzi, Z. | Lotfi, F. | Najafpour, Z. | +3

4

Factors affecting the economic burden of breast cancer in southern Iran

enthalten in: BMC health services research | 2023

von Jalali, F. | Seif, M. | Jafari, A. | +3

5

Factors affecting the economic burden of breast cancer in southern Iran

enthalten in: BMC health services research | 2023

von Jalali, F. | Seif, M. | Jafari, A. | +3

6

Correction : Economic burden of breast cancer: a case of Southern Iran

enthalten in: Cost effectiveness and resource allocation : C/E | 2023

von Jalali, F. | Keshavarz, K. | Seif, M. | +3

ErratumFor: Cost Eff Resour Alloc. 2023 Aug 29;21(1):58. - PMID 37644546

7

The Cost and Outcome of Treatment of Patients Admitted with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Shiraz, Southern Iran

enthalten in: ResearchSquare.com | 2023

von Emadi, M. | Taheri, M. | Keshavarz, K. | +1

8

Economic burden of breast cancer : a case of Southern Iran

enthalten in: Cost effectiveness and resource allocation : C/E | 2023

von Jalali, F. | Keshavarz, K. | Seif, M. | +3

ErratumIn: Cost Eff Resour Alloc. 2023 Sep 27;21(1):71. - PMID 37759289

9

Economic burden of breast cancer: a case of Southern Iran

enthalten in: Cost effectiveness and resource allocation | 2023

von Jalali, F. | Keshavarz, K. | Seif, M. | +3

10

Cost-effectiveness analysis of ceftazidime avibactam versus colistin in carbapenem-resistant enterobacteriaceae in Iran

enthalten in: Cost effectiveness and resource allocation : C/E | 2023

von Goudarzi, Z. | Danayi, F. | Keshavarz, K. | +1

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]